Literature DB >> 24628402

A review of pharmacokinetic parameters of metabolites and prodrugs.

Michel Leandro de Campos, Elias Carvalho Padilha, Rosângela Gonçalves Peccinini1.   

Abstract

In drug discovery and development, the kinetic study of active metabolites plays an important role, helping to define the time course of the drug in the body and its activity or toxicity. After a pharmacokinetics assessment of a drug and its metabolite or a prodrug and its parent-drug, several parameters can be calculated. In some cases, achieving the objective of the study does not require all possible parameters to be calculated. When parameters are calculated, it is essential that their denotations are widely accepted and used. However, some parameters undergo a certain variability of denotation, which may confuse some readers. Thus, this review summarizes the current published data for experimental pharmacokinetic parameters of metabolites and the calculations involved in simple metabolite pharmacokinetic studies. It also evaluates the most common pharmacokinetic parameters in the literature and suggests metabolite parameters that could be determined to help advance metabolite kinetic models.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24628402     DOI: 10.2174/1872312808666140317155008

Source DB:  PubMed          Journal:  Drug Metab Lett        ISSN: 1872-3128


  2 in total

1.  First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects.

Authors:  Hong Zhang; Lei Gao; Jinfeng Lou; Min Wu; Hong Chen; Lizhi Yang; Jingrui Liu; Xiaoxue Zhu; Xiaojiao Li; Cuiyun Li; Meng Wang; Chengjiao Liu; Weibo Guo; Yuan Wang; Zhongqiang Gao; Lei Han; Daidi Wang; Weili Jin; Yanhua Ding
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

Review 2.  Understanding the pharmacokinetics of reversible metabolism.

Authors:  Seungil Cho; Young-Ran Yoon
Journal:  Transl Clin Pharmacol       Date:  2019-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.